Oral etoposide in heavily pre-treated metastatic breast cancer: results from the ESME cohort and comparison with other chemotherapy regimens

Luc Cabel; Matthieu Carton; Bianca Cheaib; Jean-Yves Pierga; Florence Dalenc; Audrey Mailliez; Christelle Levy; William Jacot; Marc Debled; Marianne Leheurteur; Isabelle Desmoulins; Claudia Lefeuvre; Anthony Gonçalves; Lionel Uwer; Jean-Marc Ferrero; Jean-Christophe Eymard; Thierry Petit; Marie-Ange Mouret-Reynier; Geneviève Perrocheau; Irwin Piot; David Perol; Gaëtane Simon; Florence Lerebours

doi:10.1007/s10549-018-5017-2

Back

Oral etoposide in heavily pre-treated metastatic breast cancer: results from the ESME cohort and comparison with other chemotherapy regimens

Journal article

Peer reviewed

Oral etoposide in heavily pre-treated metastatic breast cancer: results from the ESME cohort and comparison with other chemotherapy regimens

Luc Cabel, Matthieu Carton, Bianca Cheaib, Jean-Yves Pierga, Florence Dalenc, Audrey Mailliez, Christelle Levy, William Jacot, Marc Debled, Marianne Leheurteur, …

Breast Cancer Research and Treatment

24/10/2018

DOI: https://doi.org/10.1007/s10549-018-5017-2

PMID: 30357526

Abstract

Etoposide

Metastatic breast cancer

Oral drug

HER2-negative metastatic breast cancer (MBC) is a common setting in which chemotherapy could be effective even in later lines of treatment. Oral etoposide has demonstrated clinical activity in this setting in small-scale studies, but its efficacy has not been compared to that of other chemotherapy regimens.

Files and links (1)

url

Find in HALView

Metrics

1 Record Views

Details

Title: Oral etoposide in heavily pre-treated metastatic breast cancer: results from the ESME cohort and comparison with other chemotherapy regimens
Creators - without role: Luc Cabel - Institut Curie
Matthieu Carton - Institut Curie
Bianca Cheaib - Pathologie mammaire
Jean-Yves Pierga - Institut Curie - Saint Cloud
Florence Dalenc - Institut Claudius Regaud
Audrey Mailliez - Centre Oscar Lambret
Christelle Levy - Centre François Baclesse
William Jacot - Université de Montpellier, Institut de Recherche en Cancérologie de Montpellier - IRCM
Marc Debled - Institut Bergonié
Marianne Leheurteur - Centre de Lutte Contre le Cancer Henri Becquerel Normandie Rouen
Isabelle Desmoulins - Centre Georges François Leclerc
Claudia Lefeuvre - Centre Eugène Marquis
Anthony Gonçalves - Institut Paoli-Calmettes
Lionel Uwer - Institut de Cancérologie de Lorraine
Jean-Marc Ferrero - Centre de Lutte contre le Cancer Antoine Lacassagne [Nice]
Jean-Christophe Eymard - Institut Jean Godinot
Thierry Petit - Centre Paul Strauss
Marie-Ange Mouret-Reynier - Centre Jean Perrin
Geneviève Perrocheau - Institut de Cancérologie de l'Ouest
Irwin Piot - Institut de Recherche en Cancérologie de Montpellier
David Perol - Centre Léon Bérard
Gaëtane Simon - Institut de Recherche en Cancérologie de Montpellier
Florence Lerebours - Institut Curie
Publication Details: Breast Cancer Research and Treatment
Identifiers: 9942084209311
Academic Unit: Institut de Recherche en Cancérologie de Montpellier - IRCM
Language: English
Resource Type: Journal article
Local Fields: hal-01926575